Compare NNNN & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | HYLN |
|---|---|---|
| Founded | 2021 | 2018 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2019 |
| Metric | NNNN | HYLN |
|---|---|---|
| Price | $16.79 | $8.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 21.2K | ★ 6.9M |
| Earning Date | 04-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,475,000.00 |
| Revenue This Year | N/A | $197.93 |
| Revenue Next Year | N/A | $301.97 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | ★ 130.28 |
| 52 Week Low | $10.50 | $1.31 |
| 52 Week High | $55.65 | $8.22 |
| Indicator | NNNN | HYLN |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 68.60 |
| Support Level | $14.66 | $1.79 |
| Resistance Level | $31.12 | N/A |
| Average True Range (ATR) | 3.11 | 0.98 |
| MACD | -0.97 | -0.05 |
| Stochastic Oscillator | 9.95 | 79.27 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.